Investing Profile

Kristina Burow

Photo of Kristina Burow, Managing Director at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, Berkeley Network
The University of Chicago Booth School of Business Network
ARCH Venture Partners Managing Director
$50K - $150.0M
CompanyStageDateRound SizeTotal Raised
Neumora Therapeutics
Series AOct 2021$400M
Co-investors: Robert Nelsen (ARCH Venture Partners), Stacie Weninger (F-Prime Capital Partners)
Remix Therapeutics
Series ADec 2020$65M
Co-investors: Leon Chen (The Column Group), Kevin Bitterman (Atlas Venture)
Dewpoint Therapeutics
Series BSep 2020$77M
Autobahn Therapeutics
Series BJun 2020$76M
ROME Therapeutics
Series AApr 2020$50M
Co-investors: Jim Trenkle (Sanofi Ventures), Steve Kafka (Section 32), Krishna Yeshwant (GV)
Series BApr 2020$200M
Series AMar 2019$22M
Co-investors: Jorge Conde (Andreessen Horowitz), Jonathan Lim (SignalFire), Jonathan Lim (ARCH Venture Partners)
Vir Biotechnology
Series BJan 2019$330M
Venture RoundJan 2017$150M
Co-investors: Robert Nelsen (ARCH Venture Partners)
Gossamer Bio
Series AJan 2018$100M
Managing Director ARCH Venture Partners2002 - Present
University of California, Berkeley
The University of Chicago Booth School of Business MBA